Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Jul 31,2015
Brain Protein Linked to Binge Drinking
Researchers at The Scripps Research Institute (TSRI) have discovered that a brain protein has a key role in controlling binge drinking in animal models. They found that deleting the gene for this protein in mice ramped up alcohol consumption and prevented the brain from signaling the rewarding properties of alcohol. "Alcohol hits a lot ofRead more
More
Jul 30,2015
Create 3D multiple myeloma model to aid preclinical development efforts
Multiple myeloma is an incurable cancer of the bone marrow; most patients develop resistance against first line therapy Velcade (bortezomib) sooner or later, which is a problem because few alternative drugs are available. Part of the reason for this is that to date there have been no screening systems to allow scientists to study theRead more
More
Create 3D multiple myeloma model to aid preclinical development efforts
Jul 30,2015
Takeda, Sanford-Burnham Launch Heart Failure Collaboration
Sanford-Burnham Medical Research Institute at Lake Nona said it is launching a two-year partnership with Takeda Pharmaceutical focused on treating heart failure. The value of the collaboration was not disclosed. The partners will study the potential role of several gene regulatory proteins as targets for new treatments. Researchers from Takeda and Sanford-Burnham will join colleaguesRead more
More
Jul 30,2015
Oncologists Demand Action against Rising Cancer Drug Prices
A group of 118 oncologists have called for measures to stop escalating cancer drug prices, adding their voices to those of other doctors and patient advocates who have demanded action in recent years. In a commentary to be published today in the journal Mayo Clinic Proceedings, the oncologists said they were responding to drug expensesRead more
More
Jul 29,2015
Maple Syrup May Boost Antibiotics Effectiveness
Researchers at McGill University say a concentrated extract of maple syrup makes disease-causing bacteria more susceptible to antibiotics. The findings, which will be published in Applied and Environmental Microbiology, suggest that combining maple syrup extract with common antibiotics could increase the microbes' susceptibility, leading to lower antibiotic usage. The scientists prepared a concentrated extract ofRead more
More
Jul 29,2015
Plant Protein Discovery Opens Door to Better Understanding of Human Gene Silencing
Researchers at the Van Andel Research Institute (VARI) published a paper that they say reveals a key molecular mechanism in plants that has significant similarities to certain signaling mechanisms in humans, which are closely linked to early embryonic development and to diseases such as cancer. In plants as in animals and humans, intricate molecular networksRead more
More
Jul 28,2015
Blood Holds Clues to Breast Cancer Risk
Breast cancer is the deadliest cancer for women worldwide. More than 508,000 women are estimated to have died in 2011, with nearly 1.7 million new cases diagnosed the following year (World Health Organization). A new blood test developed by University of Copenhagen researchers holds promise for finally reversing those scary numbers. The metabolic blood profile,Read more
More
Jul 28,2015
New Study Data Could Lead to Reversal of Aging Process
There are many among us who believe that time is a predator, patiently waiting for our bodies to age and yield toward its inevitable fate. However, there are few within the sciences that look at the aging process through a different lens—viewing it as a disease, one that can be treated, slowed, and possibly evenRead more
More
Jul 27,2015
3SBio Acquires Zhejiang Wansheng Pharmaceutical for $85M
3SBio said it has acquired Zhejiang Wansheng Pharmaceutical for RMB 528 million ($85 million), less than a month after completing the largest IPO of the first half of 2015. 3SBio said the acquisition will enhance its capabilities by adding an integrated small-molecule drug R&D and a manufacturing platform. Zhejiang Wansheng has 13 production lines capableRead more
More
Jul 27,2015
Biopharms Up Spending by $300 Million on Bioprocess Innovations
Innovation to improve bioprocessing efficiency is in high demand and the global biopharma industry is increasing their development spending by $300 million in 2015, according to the 12th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production from BioPlan Associates. One of the key trends listed in the study was that budgets for operationalRead more
More
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->